Clinical trial
Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in…
NCT00150566 · Shire, Industry · Completed
Key facts
| NCT number | NCT00150566 |
|---|---|
| Title | Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood |
| Official title | A Phase IIIb, Multi-center, Two-Cohort, Randomized Study, With an Open-Label Run-In and a Long-Term Extensions Phase, Assessing an Extended Dose Range of Lanthanum Carbonate in End Stage Renal Disease Subjects Receiving Hemodialysis |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic |
| Intervention type | Drug |
| Interventions | Lanthanum carbonate |
| Enrollment | 460 |
| Start date | Feb 9, 2004 |
| Primary completion | Oct 8, 2005 |
| Completion | Oct 8, 2005 |
| First posted | Sep 8, 2005 |
| Last update posted | Jun 8, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: